Treatment of Benign Essential Blepharospasm with Cyproheptadine
- 15 March 1990
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (11) , 778
- https://doi.org/10.1056/nejm199003153221116
Abstract
Benign essential blepharospasm may be severely incapacitating. The disorder is characterized by bilateral, progressively debilitating spasm of the orbicularis oculi and upper facial muscles, ultimately interfering with vision. Current pharmacologic and surgical approaches are not satisfactory, in that they require radical measures and yet are often of only temporary benefit. For example, the use of local injections of botulinus A toxin to produce neuromuscular blockade is investigational, and its effects may last only a few months1; myectomy, an operation involving the extirpation of eyelid muscles, usually requires lengthy surgery and general anesthesia.2Keywords
This publication has 5 references indexed in Scilit:
- Botulinum A Toxin Injection as a Treatment for BlepharospasmArchives of Ophthalmology (1950), 1985
- THE CALCIUM ANTAGONISTIC EFFECTS OF CYPROHEPTADINE ON CONTRACTION, MEMBRANE ELECTRICAL EVENTS AND CALCIUM INFLUX IN THE GUINEA‐PIG TAENIA COLIBritish Journal of Pharmacology, 1981
- Pharmacological characterization of serotonin receptors in the facial motor nucleus: A microiontophoretic studyEuropean Journal of Pharmacology, 1980
- Serotonergic facilitation of facial motoneuron excitationBrain Research, 1979